Sign In
Last checked at 
23 Mar 2009 07:00
|
For Immediate Release |
23 March 2009 |
ImmuPharma PLC
Directors' Dealings
Institutions increase stake
ImmuPharma PLC ("ImmuPharma" or the "Company") (LSE:IMM) announces today that a number of existing and new blue-chip institutional investors have purchased shares from the Trusts of two of ImmuPharma's founders and Directors, Richard Warr and Dimitri Dimitriou. The Trusts each placed 2.1 million (2.7 %) ordinary shares of 10 pence each in the Company at a price of 82 pence per share to institutional investors on 19 March.
Following the disposal, the current holdings are:
|
Richard Warr (1) |
9,778,968 ordinary shares |
(12.6 %) |
|
Dimitri Dimitriou (2) |
9,778,969 ordinary shares |
(12.6 %) |
(1) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest.
(2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest.
Richard Warr, ImmuPharma's Chairman said:
"We are delighted with the demand from new investors, including several blue-chip funds such as Gartmore, Smith & Williamson, Aviva and Rathbones. The allocation of these shares increases ImmuPharma's free float with the aim of improving overall liquidity."
For further information please contact:
|
ImmuPharma PLC: |
+44 20 7152 4080 |
|
Dimitri Dimitriou, Chief Executive Officer |
|
|
Richard Warr, Chairman |
|
|
Panmure Gordon |
+44 151 243 0963 |
|
Andrew Burnett/ Rakesh Sharma (Corporate Finance) |
|
|
Ashton Clanfield (Corporate Broking) |
|
|
Buchanan Communications: |
+44 20 7466 5000 |
|
Lisa Baderoon |
|
|
Rebecca Skye Dietrich |
More information on the company can be found at www.immupharma.com
Follow the stocks
